Dear Linda,
Your recent actions have revealed a troubling pursuit of profit over empathy.
Mylan’s EpiPen, now priced at a staggering $600, along with the proposed generic version at $300, effectively places a vital medication beyond the financial reach of countless hardworking families in America. Despite its production costs being minimal, you have escalated the price by an astonishing $500 in under ten years. Recently, you announced a forthcoming generic option at “half” the current price.
Families dealing with allergies know the reality. You plan to offer a generic EpiPen — which was previously available for $100 in 2007 — at a markup of 300%. Did you believe that we would express gratitude for this? Or did you think we would overlook the truth?
The fact that you are reducing the price yet it remains three times what it was less than a decade ago highlights your unyielding focus on profit. Families in need of EpiPens cannot simply save up as if preparing for a car purchase; we require this life-saving medication consistently. EpiPens expire annually, forcing many families to go through the same financial struggle each year to acquire replacements. My family, for instance, needs three packs — and our daughter isn’t even in school yet. I know families who require five or six packs, as allergies can be unpredictable and life-threatening.
The customers who can afford your exorbitant prices do so out of necessity. If we fail to make sacrifices, our loved ones are at risk. You are fully aware that there is no genuine competition in the market, enabling you to increase prices repeatedly without consequence.
You argue that lowering EpiPen prices would hurt Mylan financially, yet your salary has surged over 670% since you took over the product nearly a decade ago. With an annual earnings of $19 million, it appears no amount of wealth is enough to satisfy your ambition.
While you accumulate wealth, families like mine struggle to afford the medication that could mean the difference between life and death. Your refusal to reduce the price of EpiPens clearly indicates that Mylan’s profits and your personal gain take precedence over the lives of my daughter and millions of families who depend on EpiPens for safety.
Consider the implications of your lifestyle choices: each lavish meal at a top-tier restaurant is funded by families who forgo basic necessities so that their children can have an EpiPen. Each new luxury vehicle or vacation home represents funds that could have been spent on life-saving medication.
Your so-called philanthropy does not equate to genuine compassion. It is merely a fraction of the wealth you have extracted from families struggling to afford the medicine necessary for survival. The funding you provide to allergy organizations will never make you part of our community; it is merely a drop in the ocean compared to the suffering your pricing has caused.
Despite your attempts to portray yourself as an advocate for allergy sufferers, the reality is starkly different. You cannot buy your way into our hearts; your actions have shown us that you are out of touch with the real challenges we face.
I know our community well — we would never wish allergies on anyone, even you. We have witnessed the distress and fear that come with anaphylactic reactions. We have held our children through the panic and uncertainty, desperately hoping our EpiPens would work in time.
This isn’t a luxury for us; it’s a necessity. Interestingly, if you ever found yourself in an anaphylactic crisis, I can assure you that many in our community would rush to help you, administering the very same EpiPens you have made unaffordable for so many others. This reflects the true character of our community, one that you have exploited for far too long.
I am grateful that my daughters will belong to a community defined by empathy and kindness. They will grow to be strong, compassionate individuals who prioritize the welfare of others over personal gain. In contrast, they will have your actions as a cautionary example of how not to conduct oneself in life.
In conclusion, we hope your approach changes for the better; our community deserves leaders who genuinely care about human life.
If you’re interested in understanding the complexities of family planning and fertility, I recommend checking out this insightful resource on home insemination, as well as this excellent guide about the IVF process. For those looking to enhance fertility, boost fertility supplements can also be beneficial.
Summary
This letter addresses the excessive pricing of EpiPens by Mylan and the ethical implications of such practices. It emphasizes the struggles faced by families reliant on these life-saving medications and critiques the disconnect between corporate decisions and the real-world consequences for those in need.
Keyphrase: EpiPen pricing and ethical responsibility
Tags: [“home insemination kit” “home insemination syringe” “self insemination”]